Lili Hu

This inventor holds 37 USPTO granted patents and 5 published patent applications, plus 11 CIPO patents and 24 EPO patents, primarily in Antiviral Compounds. Top assignees: Janssen Sciences Ireland Uc, Medivir Ab, Janssen R&d Ireland. Active years: 2008-2020.

USPTO Granted Patents = 37 (Patent Applications = 5)

% Patents Active = 45.9

CIPO Patents = 11 (Patent Applications = 3)

EPO Patents = 24 (Patent Applications = 21)

Average Co-Inventor Count = 7.3

ph-index = 9

Forward Citations = 257(Granted Patents)

Location History:

Putte, BE (2014)
Beerse, BE (2013 - 2018)
Mechelen, BE (2008 - 2020)

Company Filing History:

18 out of 111

Janssen Sciences Ireland Uc

Tibotec Pharmaceuticals Ltd.

Tibotec Pharmaceuticals Ltd. Co

patent

where one patent can have more than one assignee

Years Active: 2008-2020

Loading Chart...

Areas of Expertise:

Antiviral Agents

Hepatitis C Inhibitors

RSV Inhibitors

Heterocyclic Derivatives

Macrocyclic Compounds

Spiro Compounds

Indoles

Azaindoles

Azabenzimidazoles

Pyrazolo Compounds

Benzimidazole

Imidazopyridines

37 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10875876 - Cyclized sulfamoylarylamide derivatives and the use thereof as medicaments for the treatment of hepatitis B (2020-12-29),

2. 10131673 - Piperidine substituted tricyclic pyrazolo[1,5-a]pyrimidine derivatives with inhibitory activity on the replication of the respiratory syncytial virus (RSV) (2018-11-20),

3. 9981976 - Piperidine substituted pyrazolo[1,5-A]pyrimidine derivatives with inhibitory activity on the replication of the respiratory syncytial virus (RSV) (2018-05-29),

4. 9944638 - Indoles as respiratory syncytial virus antiviral agents (2018-04-17),

5. 9896459 - Azaindoles as respiratory syncytial virus antiviral agents (2018-02-20),

6. 9890178 - Azabenzimidazoles as respiratory syncytial virus antiviral agents (2018-02-13),

7. 9856265 - Macrocyclic inhibitors of hepatitis C virus (2018-01-02),

8. 9845321 - 1,3-dihydro-2H-benzimidazol-2-one derivatives substituted with heterocycles as respiratory syncytial virus antiviral agents (2017-12-19),

9. 9738652 - Spiro urea compounds as RSV antiviral compounds (2017-08-22),

10. 9623022 - Macrocyclic inhibitors of hepatitis C virus (2017-04-18),

11. 9617289 - RSV antiviral compounds (2017-04-11),

12. 9365582 - Macrocyclic inhibitors of hepatitis C virus (2016-06-14),

13. 9353103 - Macrocyclic inhibitors of hepatitis C virus (2016-05-31),

14. 9339494 - Azaindoles as respiratory syncytial virus antiviral agents (2016-05-17),

15. 9334282 - Macrocyclic indoles as hepatitis C virus inhibitors (2016-05-10),

Title: The Innovative Journey of Lili Hu

Introduction: Lili Hu, a pioneering inventor hailing from Mechelen, Belgium, has been making significant contributions to the world of technology and innovation.

Latest Patents: Lili Hu's latest patents focus on advancements in renewable energy technologies, particularly in the field of solar power efficiency and storage solutions.

Career Highlights: With a background in engineering and a passion for sustainable solutions, Lili Hu has led groundbreaking projects that have reshaped the renewable energy landscape. Her work has been recognized globally for its impact and ingenuity.

Collaborations: Throughout her career, Lili Hu has collaborated with leading research institutions and universities to further her research and bring her inventions to life. Her partnerships have been instrumental in pushing the boundaries of innovation.

Conclusion: Lili Hu's dedication to driving positive change through innovation serves as an inspiration to aspiring inventors worldwide. Her relentless pursuit of technological advancements continues to shape a more sustainable future for generations to come.